David Neafus

David Neafus has over 28 years of experience in finance and executive roles. David began their career as the CEO of Triton Resources, Inc. in 1992, where they provided CFO/finance help or interim CFO help. In 2017, they became the CFO of Panther Pharmaceuticals, Inc. and has since held CFO roles at Avilar Therapeutics, Inc., Qlaris Bio, Inc., NControl Therapeutics, Nayan Therapeutics, Inc., Triana Biosciences (Formerly Santi), Arramis Biosciences, Inc., and Odyssey Therapeutics. David is currently the Chief Financial Officer of Virion Therapeutics.

David Neafus earned their MBA in Finance from Bentley University in 1992, following their BS in Accounting from the University of Minnesota in 1987.